ArticleIrish journal of medical science2026
NMR-based metabolic profiling in urine for bipolar disorder manic episode.
Article in Irish journal of medical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBipolar disorder is a chronic psychiatric condition characterised by recurrent manic, hypomanic, and depressive episodes. Despite its substantial burden, Bipolar disorder lacks validated biological biomarkers, and diagnosis continues to rely on subjective clinical assessment. Urinary metabolomics-based nuclear magnetic resonance spectroscopy offers a non-invasive approach to characterising systemic metabolic alterations associated with psychiatric illness.
aimsThis study aimed to annotate urinary metabolic alterations and dysregulated metabolic pathways in patients with Bipolar disorder during a manic episode, compared with healthy controls, using an untargeted H1NMR metabolomics approach.
methodsFirst-morning urine samples were collected from 19 patients experiencing a manic episode and 27 healthy controls. Metabolite annotation was supported by one- and two-dimensional NMR spectroscopy and database matching. Between-group differences were assessed using the limma moderated t-test with Benjamini-Hochberg false discovery rate correction. Multivariate analyses included principal component analysis, PERMANOVA, and exploratory orthogonal partial least-squares discriminant analysis. Pathway enrichment and topology analysis were performed using MetaboAnalyst 6.0.
resultsAfter FDR correction, uracil and taurine were significantly decreased in the manic episode group. Pathway analysis annotated five significantly enriched pathways: taurine and hypotaurine metabolism, primary bile acid biosynthesis, pyrimidine metabolism, pantothenate and CoA biosynthesis, and β-alanine metabolism. Multivariate analyses revealed a statistically significant but modest group-related metabolic difference, with limited discriminatory performance in OPLS-DA modelling.
conclusionThis pilot study annotated exploratory urinary metabolic alterations in treated patients with BD during a manic episode. These findings are hypothesis-generating and require validation in larger, longitudinal, independent cohorts.
Indexed as
Identifiers
42782583What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.